Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Smiths News lifts FY profit outlook after strong second half

(Sharecast News) - Smiths News lifted its full-year profit outlook on Tuesday following strong trading in the second half. The news wholesaler now expects profit for FY25 to be "slightly ahead" of current market expectations of £37.2m. This performance has been driven by the news and magazines business, which has been boosted by strong demand for collectables, and continued focus on operational efficiencies, delivering cost-savings in line with expectations, it said.

Smiths also said it had received a final £2m dividend from the administrators of McColl's Retail Group.

The company said it continues to consider investment in its core capabilities, potential adjacent market opportunities and further shareholder returns.

Chief executive Jonathan Bunting said: "The group's performance in FY2025 reflects the continued dedication and strategic discipline of our team, maintaining a clear focus on the news and magazines business, whilst extending our market reach in a targeted and sustainable manner.

"As we move into FY2026, the business continues to perform well, and I look forward to sharing a more detailed update on our progress at the company's full year results in November."

At 0858 BST, the shares were up 2.7% at 60.63p.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.